John Dzundza

Professor John Dzundza is focused on real-world applications of venous thromboembolism prophylaxis and its impact on patient care. As an Associate Professor of Medicine at the University of California, San Francisco, he is deeply engaged in research that seeks to enhance the understanding and management of venous thromboembolism, particularly in hematopoietic cell transplant patients. His work is pivotal in developing strategies that aim to prevent complications and improve the quality of life for these patients. Dr. Dzundza's research extends to the management of febrile neutropenia in hospitalized adults, a critical area that affects patient outcomes significantly. He has been instrumental in publishing studies that evaluate and refine protocols and algorithms designed to optimize care and reduce risks associated with these conditions. His contributions to the field are recognized for their practical implications in clinical settings, helping to guide healthcare professionals in making informed decisions. With a commitment to advancing medical knowledge, Dr. Dzundza collaborates with interdisciplinary teams to explore innovative solutions and evidence-based practices. His dedication to research and education not only enhances patient care but also serves as a valuable resource for students and colleagues at the University of California, San Francisco. Through his work, he continues to influence the field of medicine, particularly in the areas of thrombosis and infection management.